CClinicalTrials.gg
CompletedNCT03429634Updated Feb 12, 2018

Balloon-Stent Kissing Technique Versus Jailed Wire Technique for the Coronary Bifurcation Lesions

An Early Phase 1 interventional study of Balloon-Stent Kissing technique and Jailed Wire technique in Coronary Artery Disease, sponsored by Dalian University. Completed at 1 site in China. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2018-02-12.

Sponsored by Dalian University · Early Phase 1, Interventional, and Treatment

Phase
Early Phase 1
Study type
Interventional
Enrollment
89
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

To compare the immediate and long-term clinical outcomes between Balloon-Stent Kissing Technique (BSKT) and Jailed Wire Technique (JWT) for the interventional treatment of coronary bifurcation lesions.

Read the detailed description

Coronary bifurcation lesions account for 15-20% of percutaneous coronary interventions (PCIs)[1-2]. They have lower success rate after operation, higher re-stricture ratio by radiography and frequent complications, which result in adverse clinical outcomes as compared to non-bifurcation lesions[3-5]. Secure and efficient treatment strategies for PCI and bifurcation lesions are research hotspots for cardiovascular surgeons. Single-side stand strategy (main-support implantation stand or side-support implantation stand when necessary) is currently preferred for bifurcation lesions[2,6]. However, as main-support implantation stand could lead to plaque transposition, bifurcation ridge excursion and side a sandwich, the side openings could become narrower or even blocked[7]. In 2011, our centre initiated the use of balloon-stent kissing technique (BSKT)[8] to protect the side branch, which has higher success rate after operation, lower block ratio of side branch and lower incidence of perioperative adverse events, which led to immediate clinical effect. This study compared BSKT versus Jailed Wire Technique (JWT) in the interventional treatment of coronary bifurcation lesions to further clarify BSKT's efficacy and advantages.

02

Conditions studied

  • Coronary Artery Disease
03

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

    1. patients with CHD; 2. coronary arteriography revealed true bifurcation lesion

Exclusion criteria

Exclusion Criteria:

    1. severe carcified lesion; 2. left main lesion; 3. severe heart failure(NYHA grade 4)
04

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
89 participants (actual)

Study arms

  • Experimental
    Balloon-Stent Kissing technique

    randomly, patients with bifurcation lesion treated by Balloon-Stent Kissing intervention technique in this group.For procedure,stent in main vessel and balloon protect of side branch,final kiss-balloon was performed.

    Procedure: Balloon-Stent Kissing technique · Procedure: Jailed Wire technique

  • Sham comparator
    Jailed Wire technique

    randomly,patients with bifurcation lesion treated by Jailed Wire intervention technique in this group.For procedure,stent in main vessel and only wire protect of side branch.If need,post-stent rewire of branch,and balloon dilation of side branch was performed.

    Procedure: Balloon-Stent Kissing technique · Procedure: Jailed Wire technique

Interventions

  • ProcedureBalloon-Stent Kissing technique

    All patients underwent coronary angiogram that confirmed true bifurcation lesions, and received PCI treatment,Balloon-Stent Kissing Technique (BSKT)for the interventional treatment of coronary bifurcation lesion

  • ProcedureJailed Wire technique

    All patients underwent coronary angiogram that confirmed true bifurcation lesions, and received PCI treatment, Jailed Wire technique(JWT) for the interventional treatment of coronary bifurcation lesion

05

What researchers measure

Primary outcomes

  1. Perioperative major adverse cardiovascular (MACE) events (%)

    total percent of cardiac death, perioperative myocardial infarction and target lesion revascularization

    Time frame: up to 72hr after PCI

Secondary outcomes

  1. long-term clinical outcomes(%)

    total percent of angina pectoris, CCS classification ≥Ⅱ level and severe heart failure (NYHA class),cardiac death, perioperative myocardial infarction and target lesion revascularization

    Time frame: post-PCI to mean 19 month follow up

06

Study locations

1 site
  • Dept. of Cardiology, Affiliated Zhongshan hospital of Dalian University
    Dalian, Liaoning 116001, China
07

References and documents

Publications

  • Lassen JF, Holm NR, Stankovic G, Lefevre T, Chieffo A, Hildick-Smith D, Pan M, Darremont O, Albiero R, Ferenc M, Louvard Y. Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings. EuroIntervention. 2014 Sep;10(5):545-60. doi: 10.4244/EIJV10I5A97. PubMed 25256198 ↗

Individual participant data

Plan to share: Undecided

08

Registry details

Key details

Study ID
NCT03429634
Lead sponsor
Dalian University
Responsible party
Sponsor
First posted
Feb 12, 2018
Start date
Jan 1, 2013
Primary completion
May 1, 2016
Completion
Jul 1, 2017
Last update
Feb 12, 2018

Study contacts

zhenguo Zheng, Dr.
study director · zhongshan Hospital affiliated to dalian University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion